444

KAKEN PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪129.49 B‬JPY
‪5.44 B‬JPY
‪72.98 B‬JPY
‪23.50 M‬
Beta (1Y)
0.41

About KAKEN PHARMACEUTICAL

Headquarters
Tokyo
Employees (FY)
‪1.13 K‬
Founded
1948
ISIN
JP3207000005
FIGI
BBG000BJWCY6
Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operations are carried out through the Pharmaceutical and Real Estate business segments. The Pharmaceutical segment mainly manufactures and sells pharmaceuticals, medical devices and agricultural chemicals. The Real Estate segment rents real estate related to Bunkyo Green Court. The company was founded in March 1917 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4521 is 3423 JPY — it has increased by 1.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange KAKEN PHARMACEUTICAL stocks are traded under the ticker 4521.
KAKEN PHARMACEUTICAL is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
4521 stock is 1.33% volatile and has beta coefficient of 0.41. Check out the list of the most volatile stocks — is KAKEN PHARMACEUTICAL there?
One year price forecast for KAKEN PHARMACEUTICAL has a max estimate of 3500 JPY and a min estimate of 3500 JPY.
Yes, you can track KAKEN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
4521 stock has risen by 0.15% compared to the previous week, the month change is a 3.03% fall, over the last year KAKEN PHARMACEUTICAL has showed a 7.24% decrease.
Like other stocks, 4521 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KAKEN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
4521 reached its all-time high on Aug 18, 2015 with the price of 12720 JPY, and its all-time low was 822 JPY and was reached on Dec 19, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪1.13 K‬ employees. See our rating of the largest employees — is KAKEN PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KAKEN PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KAKEN PHARMACEUTICAL stock shows the sell signal. See more of KAKEN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on KAKEN PHARMACEUTICAL future price: according to them, 4521 price has a max estimate of 3500.00 JPY and a min estimate of 3500.00 JPY. Read a more detailed KAKEN PHARMACEUTICAL forecast: see what analysts think of KAKEN PHARMACEUTICAL and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KAKEN PHARMACEUTICAL EBITDA is ‪7.23 B‬ JPY, and current EBITDA margin is 14.48%. See more stats in KAKEN PHARMACEUTICAL financial statements.